Company Overview of Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the discovery and development of small-molecule antiviral therapeutics for hepatitis C virus (HCV). Its product pipeline includes PPI-668, a pan-genotypic HCV NS5A inhibitor for the treatment of patients with chronic HCV; and PPI-383, a non-nucleoside polymerase inhibitor to treat HCV. Presidio Pharmaceuticals, Inc. was incorporated in 2006 and is based in San Francisco, California.
1700 Owens Street
San Francisco, CA 94158
Founded in 2006
Key Executives for Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|DrNatura.com Inc.||United States|
|DaVita Clinical Research||United States|
|The Horrocks Company, LLC||United States|
|Hapten Sciences, Inc.||United States|
|Bennu Pharmaceuticals Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Chicago, IL | PwCPosted: Aug 20
- Florham Park, NJ | PwCPosted: Aug 20
- Philadelphia, PA | PwCPosted: Aug 20
Sponsored Financial Commentaries
To contact Presidio Pharmaceuticals, Inc., please visit www.presidiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.